Two Sigma Advisers
ADMA icon

Two Sigma Advisers’s ADMA Biologics ADMA Stock Holding History

Two Sigma Advisers’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,800
Closed -$471K – 39
2025
Q4 		$471K Sell
25,800
-106,000
-80% -$1.79M ﹤0.01% 1809
2025
Q3 		$1.93M Sell
131,800
-901,600
-87% -$15.5M ﹤0.01% 1153
2025
Q2 		$18.8M Sell
1,033,400
-1,553,200
-60% -$31.7M 0.04% 352
2025
Q1 		$51.3M Sell
2,586,600
-363,524
-12% -$6.29M 0.12% 181
2024
Q4 		$50.6M Sell
2,950,124
-1,504,276
-34% -$28.3M 0.12% 165
2024
Q3 		$89M Sell
4,454,400
-200,200
-4% -$3.11M 0.21% 95
2024
Q2 		$52M Buy
4,654,600
+1,195,000
+35% +$10M 0.12% 165
2024
Q1 		$22.8M Buy
3,459,600
+682,000
+25% +$3.73M 0.05% 313
2023
Q4 		$12.6M Sell
2,777,600
-388,500
-12% -$1.44M 0.03% 449
2023
Q3 		$11.3M Buy
3,166,100
+406,200
+15% +$1.56M 0.03% 435
2023
Q2 		$10.2M Buy
2,759,900
+751,300
+37% +$2.78M 0.03% 476
2023
Q1 		$6.65M Buy
2,008,600
+1,446,400
+257% +$5M 0.02% 693
2022
Q4 		$2.18M Buy
562,200
+535,500
+2,006% +$1.65M 0.01% 1194
2022
Q3 		$65K Buy
+26,700
New +$64.1K ﹤0.01% 2355
2020
Q1 		– Sell
-11,000
Closed -$44K – 2444
2019
Q4 		$44K Buy
+11,000
New +$47.9K ﹤0.01% 2295

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Two Sigma Advisers's ADMA Position: Q1 2026 in Review

Two Sigma Advisers sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 25,800 shares — an estimated $471K sold.

Two Sigma Advisers first reported a position in ADMA in Q4 2019 and held it in 15 quarters. The position peaked at $89M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Two Sigma Advisers reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 25,800 ADMA Biologics shares in Q1 2026, an estimated $471K.
  • Two Sigma Advisers first reported a position in ADMA Biologics in Q4 2019 and held it in 15 quarters.
  • Two Sigma Advisers's ADMA Biologics position peaked at $89M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.